Provided by Tiger Fintech (Singapore) Pte. Ltd.

Titan Pharmaceuticals

4.69
-0.0868-1.82%
Post-market: 4.690.00000.00%16:00 EDT
Volume:10.91K
Turnover:51.46K
Market Cap:6.24M
PE:-1.02
High:4.95
Open:4.62
Low:4.62
Close:4.78
Loading ...
Aug 17, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 16, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Major Issues Report

8-K - Current report
Jul 22, 2022

Major Issues Report

8-K - Current report
Jul 13, 2022

Major Issues Report

8-K - Current report
Jul 11, 2022

Major Issues Report

8-K - Current report
Jul 08, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 05, 2022

Major Issues Report

8-K - Current report
Jun 09, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 02, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2022

Major Issues Report

8-K - Current report
Apr 25, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 04, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 31, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 31, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 28, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals